ArticleSaudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
Stand-alone pars plana vitrectomy versus pars plana vitrectomy with retinopexy for retinal vasoproliferative tumors.
Article in Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Acute postoperative complications after scleral fixation of Akreos AO60 intraocular lens.Journal of surgical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe purpose of this study was to compare surgical indications, functional outcomes, and postoperative complications of stand-alone pars plana vitrectomy (PPV) versus PPV with retinopexy for retinal vasoproliferative tumors (RVPTs).
methodsRetrospective multicenter cohort study: 12 consecutive pars plana vitrectomies in 12 eyes with RVPTs performed either stand alone (Group S), or associated with intraoperative retinopexy on the RVPT (Group R) between April 2017 and December 2020 were included.
resultsSurgical indications included epiretinal membranes (ERMs) (42%), vitreous opacities (25%), recurrent-persistent vitreous hemorrhage (VH) (17%), rhegmatogenous retinal detachment with proliferative vitreoretinopathy (8%), and biopsy of retinal lesion (8%). The mean preoperative best-corrected visual acuity (BCVA) was 0.97 ± 0.78 logarithm of the minimal angle of resolution (logMAR) in Group S and 1.09 ± 0.67 in Group R (
conclusionVitrectomy in RVPTs seemed efficacious and safe for certain indications. Functional outcomes and complications appeared to be superior in eyes which underwent retinopexy on RVPTs compared to the stand-alone vitrectomy group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.